AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Coding, coverage, and payment for clinical laboratory services, including the Medicare clinical laboratory fee schedule and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation of laboratory diagnostics and related FDA and CMS policies; artificial intelligence in laboratory services; utilization management, including prior authorization impacting clinical laboratories.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS | — |
Medicare/Medicaid MMM
Coding, coverage, and payment for clinical laboratory services, including the Medicare clinical laboratory fee schedule and implementation of the Protecting Access to Medicare Act (P.L. 113-93).
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS | — |
Health Issues HCR
Coding, coverage, and payment for clinical laboratory services, including the Medicare clinical laboratory fee schedule and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation of laboratory diagnostics and related FDA and CMS policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.